These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9593104

  • 1. Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach.
    Breier A, Adler CM, Weisenfeld N, Su TP, Elman I, Picken L, Malhotra AK, Pickar D.
    Synapse; 1998 Jun; 29(2):142-7. PubMed ID: 9593104
    [Abstract] [Full Text] [Related]

  • 2. Effects of atypical antipsychotic drug treatment on amphetamine-induced striatal dopamine release in patients with psychotic disorders.
    Breier A, Su TP, Malhotra AK, Elman I, Adler CM, Weisenfeld NI, Pickar D.
    Neuropsychopharmacology; 1999 Apr; 20(4):340-5. PubMed ID: 10088134
    [Abstract] [Full Text] [Related]

  • 3. Ketamine does not decrease striatal dopamine D2 receptor binding in man.
    Aalto S, Hirvonen J, Kajander J, Scheinin H, Någren K, Vilkman H, Gustafsson L, Syvälahti E, Hietala J.
    Psychopharmacology (Berl); 2002 Dec; 164(4):401-6. PubMed ID: 12457270
    [Abstract] [Full Text] [Related]

  • 4. Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.
    Vollenweider FX, Vontobel P, Oye I, Hell D, Leenders KL.
    J Psychiatr Res; 2000 Dec; 34(1):35-43. PubMed ID: 10696831
    [Abstract] [Full Text] [Related]

  • 5. NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans.
    Kegeles LS, Martinez D, Kochan LD, Hwang DR, Huang Y, Mawlawi O, Suckow RF, Van Heertum RL, Laruelle M.
    Synapse; 2002 Jan; 43(1):19-29. PubMed ID: 11746730
    [Abstract] [Full Text] [Related]

  • 6. Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects.
    Smith GS, Schloesser R, Brodie JD, Dewey SL, Logan J, Vitkun SA, Simkowitz P, Hurley A, Cooper T, Volkow ND, Cancro R.
    Neuropsychopharmacology; 1998 Jan; 18(1):18-25. PubMed ID: 9408915
    [Abstract] [Full Text] [Related]

  • 7. Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition.
    Pedersen K, Simonsen M, Østergaard SD, Munk OL, Rosa-Neto P, Olsen AK, Jensen SB, Møller A, Cumming P.
    Neuroimage; 2007 Mar; 35(1):38-46. PubMed ID: 17223363
    [Abstract] [Full Text] [Related]

  • 8. NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys.
    Adams BW, Bradberry CW, Moghaddam B.
    Synapse; 2002 Jan; 43(1):12-8. PubMed ID: 11746729
    [Abstract] [Full Text] [Related]

  • 9. Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography.
    van Berckel BN, Kegeles LS, Waterhouse R, Guo N, Hwang DR, Huang Y, Narendran R, Van Heertum R, Laruelle M.
    Neuropsychopharmacology; 2006 May; 31(5):967-77. PubMed ID: 16177807
    [Abstract] [Full Text] [Related]

  • 10. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
    Narendran R, Hwang DR, Slifstein M, Talbot PS, Erritzoe D, Huang Y, Cooper TB, Martinez D, Kegeles LS, Abi-Dargham A, Laruelle M.
    Synapse; 2004 Jun 01; 52(3):188-208. PubMed ID: 15065219
    [Abstract] [Full Text] [Related]

  • 11. 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.
    Vollenweider FX, Vontobel P, Hell D, Leenders KL.
    Neuropsychopharmacology; 1999 May 01; 20(5):424-33. PubMed ID: 10192823
    [Abstract] [Full Text] [Related]

  • 12. Effects of acute metabolic stress on striatal dopamine release in healthy volunteers.
    Adler CM, Elman I, Weisenfeld N, Kestler L, Pickar D, Breier A.
    Neuropsychopharmacology; 2000 May 01; 22(5):545-50. PubMed ID: 10731630
    [Abstract] [Full Text] [Related]

  • 13. Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats.
    Ginovart N, Wilson AA, Houle S, Kapur S.
    Biol Psychiatry; 2004 Jun 15; 55(12):1188-94. PubMed ID: 15184038
    [Abstract] [Full Text] [Related]

  • 14. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria.
    Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, Grace AA, Price JL, Mathis CA.
    Biol Psychiatry; 2001 Jan 15; 49(2):81-96. PubMed ID: 11164755
    [Abstract] [Full Text] [Related]

  • 15. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.
    Kegeles LS, Abi-Dargham A, Zea-Ponce Y, Rodenhiser-Hill J, Mann JJ, Van Heertum RL, Cooper TB, Carlsson A, Laruelle M.
    Biol Psychiatry; 2000 Oct 01; 48(7):627-40. PubMed ID: 11032974
    [Abstract] [Full Text] [Related]

  • 16. GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scans.
    Villemagne VL, Wong DF, Yokoi F, Stephane M, Rice KC, Matecka D, Clough DJ, Dannals RF, Rothman RB.
    Synapse; 1999 Sep 15; 33(4):268-73. PubMed ID: 10421707
    [Abstract] [Full Text] [Related]

  • 17. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method.
    Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D.
    Proc Natl Acad Sci U S A; 1997 Mar 18; 94(6):2569-74. PubMed ID: 9122236
    [Abstract] [Full Text] [Related]

  • 18. Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography.
    Hartvig P, Torstenson R, Tedroff J, Watanabe Y, Fasth KJ, Bjurling P, Långström B.
    J Neural Transm (Vienna); 1997 Mar 18; 104(4-5):329-39. PubMed ID: 9295169
    [Abstract] [Full Text] [Related]

  • 19. Effects of amphetamine and evoked dopamine release on [11C]raclopride binding in anesthetized cats.
    Ginovart N, Hassoun W, Le Cavorsin M, Veyre L, Le Bars D, Leviel V.
    Neuropsychopharmacology; 2002 Jul 18; 27(1):72-84. PubMed ID: 12062908
    [Abstract] [Full Text] [Related]

  • 20. Imaging endogenous dopamine competition with [11C]raclopride in the human brain.
    Volkow ND, Wang GJ, Fowler JS, Logan J, Schlyer D, Hitzemann R, Lieberman J, Angrist B, Pappas N, MacGregor R.
    Synapse; 1994 Apr 18; 16(4):255-62. PubMed ID: 8059335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.